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Summary
Leukotriene B4 (LTB4) is a neutrophil chemotactic molecule with impor-
tant involvement in the inflammatory responses of chronic obstructive
pulmonary disease (COPD). Airway epithelium is emerging as a regulator
of innate immune responses to a variety of insults including cigarette
smoke, the major risk factor for COPD. In this study we have explored
whether cigarette smoke extracts (CSE) or soluble mediators present in
distal lung fluid samples (mini-bronchoalveolar lavages) from smokers
alter the expression of the LTB4 receptor 2 (BLT2) and peroxisome prolif-
erator-activated receptor-a (PPAR-a) in bronchial epithelial cells. We also
evaluated the effects of CSE on the expression of intercellular adhesion
molecule 1 (ICAM-1) and on the binding of signal transducer and activa-
tor of transcription 1 (STAT-1) to ICAM-1 promoter as well as the
adhesiveness of neutrophils to bronchial epithelial cells. CSE and mini-
bronchoalveolar lavages from smokers increased BLT2 and ICAM-1
expression as well as the adhesiveness of neutrophils to bronchial epithe-
lial cells and decreased PPAR-a expression. CSE induced the activation of
STAT-1 and its binding to ICAM-1 promoter. These findings suggest that,
in bronchial epithelial cells, CSE promote a prevalent induction of
pro-inflammatory BLT2 receptors and activate mechanisms leading to
increased neutrophil adhesion, a mechanism that contributes to airway
neutrophilia and to tissue damage.
Keywords: bronchial epithelial cells; cigarette smoke; chronic obstructive
pulmonary disease; inflammation; leukotriene B4.
Introduction
The airway epithelium plays a role in airway defence
mechanisms by releasing cytoprotective mucus and defen-
sins and exerts an important role in co-ordinating local
inflammation and immune responses through the release
of cytokines and chemokines.1 Leukotriene B4 (LTB4) is a
mediator with important involvement in the inflamma-
tory responses in chronic obstructive pulmonary disease
(COPD).2 Chronic neutrophilic inflammation is observed
in COPD and mediates extensive tissue damage
contributing to organ dysfunction.3 Activated neutrophils
release elastase, a protease that correlates with LTB4,
4 that
actively contributes to generating the lung damage in
COPD patients. Purulent exacerbations in these patients
are related to bacterial infections, and are associated with
further increased neutrophilic inflammation and increased
LTB4 concentrations.
5
Leukotriene B4 is able to interact with two cell-surface
receptors LTB4 receptor 1 (BLT1) and LTB4 receptor 2
Abbreviations: BAL, bronchoalveolar lavages; COPD, chronic obstructive pulmonary disease; CSE, cigarette smoke extracts;
ICAM-1, intercellular adhesion molecule 1; LTB4, leukotriene B4; NF-jB, nuclear factor-jB; PPAR-a, peroxisome proliferator-
activated receptor-a
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(BLT2) and with a nuclear receptor named peroxisome
proliferator-activated receptor-a (PPAR-a). The interac-
tion of LTB4 with the cell-surface receptors induces
LTB4-mediated inflammatory activities while the interac-
tion with PPAR-a induces the catabolism of LTB4 and in
turn limits LTB4-related inflammation.
6 We have previ-
ously demonstrated, in a model of pleural inflammation,
that the prevalent activation of pro-inflammatory LTB4
receptors in the presence of an inflammatory milieu may
lead to up-regulation of intercellular adhesion molecule 1
(ICAM-1) and to increased adhesion between neutrophils
and the mesothelium, resulting in neutrophil retention on
the surface of mesothelial cells.7
Although increased expression of BLT1 and of PPAR-a
has been observed in distal airways of patients with
COPD,8 the molecular mechanisms involved in this phe-
nomenon are largely unknown. The aims of the present
study were to test whether cigarette smoke extracts (CSE)
alter the expression of both BLT-2 and PPAR-a and to
assess whether this alteration is the result of a direct effect
of CSE or of the inflammatory responses promoted by
cigarette smoke. The experiments were performed in
bronchial epithelial cells stimulated with CSE or with
mini-bronchoalveolar lavage (BAL) from smokers and the
expression of BLT2 and PPAR-a as well as the neutrophil
–epithelial cell adhesion were assessed.
Materials and methods
Patient population
Smoking subjects (> 15 packs/year) (n = 8) and non-
smoking subjects (n = 4) with acute respiratory failure
upon surgery for abdominal or thoracic aneurysm were
recruited. Patients with X-ray or clinical evidence of sep-
sis or pneumonia at the time of mini-BAL collection were
not included. All recruited subjects required mechanical
ventilation and underwent therapy with antibiotics and
systemic corticosteroids (no significantly different doses
among the patients included in the study). Tissue speci-
mens from central bronchi from smoking (> 15 packs/
year) and from non-smoking subjects were also collected.
The study fulfilled the criteria of the Ethics Committee of
Policlinico-Giaccone Hospital, Palermo and was in agree-
ment with the Helsinki Declaration. Informed written
consent from either the patients or their closest relatives
was obtained.
Mini-BAL collection and processing
Distal lung fluid samples (mini-BALs) were obtained using
bronchoscopic aspirate sampling catheters (Kimberly-
Clark Health Care, West Malling, Kent, UK) within 1 hr
from the intubation.9 The protected catheter was blindly
advanced through the endotracheal tube until it was
wedged into a distal airway and two aliquots of 10 ml
sterile 09% NaCl were instilled and gently suctioned
(recovered volume about 70% of the instilled volume).
Mini-BAL samples were filtered through a sterile gauze
and then centrifuged at 300 g for 10 min to separate cells
from supernatants. The supernatants were used for stimu-
lating bronchial epithelial cells.
Immunohistochemistry
Tissue specimens from central bronchi were selected, fixed
with 10% neutral buffered formalin and embedded in par-
affin wax. Three-micrometer tissue sections were attached
to poly-L-lysine-coated microscope slides and, after
dewaxing and rehydration, were stained with haematoxy-
lin and eosin or analysed with immunohistochemistry.
Immunohistochemistry and image analysis were used
to determine BLT2 and PPAR-a expression using rabbit
polyclonal antibodies (Cayman Chemical, Ann Arbor,
MI) in central (internal perimeter > 6 mm) airways.
LSAB2 Dako kit (Code No. K0674) (Dako, Glostrup,
Denmark) and Fuchsin Substrate-Chromogen System
Dako were used for the staining. Non-immune rabbit
(Dako) was used as negative control. The immunoreactiv-
ity was evaluated blindly by two independent investigators
using a Leica (Wetzlar, Germany) microscope 9 400
magnification.
Preparation of cigarette smoke extracts
Commercial cigarettes (Marlboro) were used in this
study. Cigarette smoke solution was prepared as described
previously.10 Each cigarette was smoked for 5 min and
one cigarette was used per 25 ml PBS to generate a CSE-
PBS solution. The CSE solution was filtered through a
022-lm pore filter to remove bacteria and large particles.
The smoke solution was then adjusted to pH 74 and
used within 30 min of preparation. This solution was
considered to be 100% CSE and was diluted to obtain the
desired concentration in each experiment. The concentra-
tion of CSE was calculated spectrophotometrically mea-
suring the optical density (OD) as previously described11
at a wavelength of 320 nm. The pattern of absorbance
showed very little difference among different batches and
the mean OD of the different batches was 137  016.
The presence of contaminating lipopolysaccharide on
undiluted CSE was assessed by a commercially available
kit (Cambrex Corporation, East Rutherford, NJ) and was
below the detection limit of 01 EU/ml.
Bronchial epithelial cell cultures
The human bronchial epithelial SV40 immortalized cell
line 16HBE was used in this study.12 16HBE cells were
maintained in minimium essential medium (MEM;
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Gibco, Life Technologies, Carlsbad, CA), supplemented
with 10% fetal calf serum (Gibco) and 05% gentamicin
(Gibco). Cell cultures were maintained in a humidified
atmosphere of 5% CO2 in air at 37°. The cells were cul-
tured in the presence and absence of CSE and in the
presence and absence of mini-BAL from smokers or non-
smokers for 18 hr. The concentration of CSE used, 10%,
was selected on the basis of cell apoptosis/necrosis experi-
ments. The time-point was selected on the basis of preli-
minary experiments (data not shown). At the end of
stimulation, cell pellets, cell extracts and cell culture su-
pernatants were collected for further evaluations. In some
experiments a BLT2 antagonist (LY255283) (10 lM) or a
PPAR-a antagonist (MK886) (10 lM) (Cayman Chemical)
was added 1 hr before cell stimulation, as previously
described.7,13,14 The concentrations of both LY255283 and
MK886 were selected by performing a dose–response
experiment (see Supplementary material, Fig. S1).The 20-
lM concentration for both inhibitors was discarded
because it induced cell morphology alterations.
Cell necrosis and cell apoptosis
Cell necrosis and cell apoptosis were evaluated, as previ-
ously described,9 by staining with annexin V-FITC and
propidium iodide using a commercial kit (Bender MedSys-
tem, Vienna, Austria) following the manufacturer’s direc-
tions. Cells were analysed using a FACS Calibur (Becton
Dickinson, Mountain View, CA) analyser equipped with
an Argon ion Laser (Innova 70 Coherent, Santa Clara, CA).
BLT2 and PPAR-a expression
The expression of BLT2 and of PPAR-a in 16HBE cells
was evaluated by flow cytometry using rabbit polyclonal
antibodies anti-BLT2 and anti-PPAR-a (both from Cay-
man Chemical) (1 : 250 for 1 hr) followed by an FITC-
conjugated anti-rabbit IgG (Dako). To evaluate the
expression of BLT2 and of PPAR-a before incubation
with rabbit polyclonal antibodies, cells were permeabilized
using a commercial fix-perm cell permeabilization kit
(Caltag Laboratories, Burlingame, CA). Negative controls
were performed using non-immune rabbit (Dako). Data
are expressed as GeoMean fluorescence intensity and as
percentage of positive cells.
Cell-adhesion assay
Cell-adhesion assay was performed by a method previ-
ously described with minor modifications.15 Briefly,
16HBE cells were seeded in 96-well plates at half-
confluency and kept for 18 hr alone and with mini-BAL
supernatants from smokers. Peripheral blood neutrophils
were isolated from peripheral blood of normal donors as
previously described,16 labelled for 30 min with 20 lM of
fluorocromic dye SFDA (Molecular Probes, Eugene, OR)
and washed and resuspended in PBS (1 9 105/ml).
Immediately before the addition of neutrophils, the
16HBE cultures were washed with warm PBS. Labelled
neutrophils were added in a final volume of 01 ml
(1 9 104/well). The plates were incubated at 37° for
20 min to allow neutrophils to contact and to adhere to
the confluent 16HBE, and total fluorescence was mea-
sured using an excitation wavelength of 485 nm and
monitoring emission at 530 nm in a Wallac 1420 Victor
multilabel counter (PerkinElmer Life and Analytical Sci-
ences-Wallac OY, Turku, Finland). Non-adherent cells
were then removed by washing and fluorescence was
measured to evaluate bound cells. Adhesion was expressed
as percentage of the fluorescence ratio of bound cells over
total cells. All test points were performed in triplicate.
The baseline values represent the adhesion of neutrophils
to unstimulated cells.
Evaluation of ICAM-1 expression
The expression of ICAM-1 on the surface of bronchial
epithelial cells was determined by flow cytometry. An
FITC-conjugated mouse anti-human ICAM-1 antibody
(anti-CD54; clone 6.5B5; Dakopatts, Glostrup, Denmark)
was used. Negative controls were performed using a
non-immune FITC-conjugated mouse IgG1 (from
Dakopatts). Data are expressed as GeoMean fluorescence
intensity.
RNA interference and transfection
Cells were plated in 24-well tissue culture plates and
grown in medium containing 10% FBS without the use
of antibiotic until 60–80% confluency. BLT2 or PPAR-a
small interfering (si) RNA (10 lM; Santa Cruz Biotech-
nology, Inc., Dallas, TX) were added to 40 ll siRNA
transfection medium, and the reaction was performed
according to the manufacturer’s instructions until com-
plete transfection of cells (30 hr at 37°). For optimal
siRNA transfection efficiency, control siRNA (10 lM;
Santa Cruz Biotechnology Inc.) was used containing a
scrambled sequence that did not lead to the specific
degradation of any known cellular mRNA. Finally, cells
were stimulated with CSE 10% for 18 hr, and ICAM-1
expression was evaluated. The silencing efficacy of the
RNA interference was checked by flow cytometry.
Western blot analysis for STAT-1
Western blot analysis for signal transducer and activator
of transcription 1 (STAT-1) was performed as previously
described7 with some modifications. Briefly, 16HBE cells
were lysed (10 mM Tris–HCl, pH 74; 50 mM NaCl; 5 mM
EDTA; 1% Nonidet P-40; 10 lg/ml PMSF) and protein
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were extracted. A 50-lg sample total proteins was sub-
jected to SDS–PAGE on 4–12% gradient gels (Novex, San
Diego, CA) and blotted onto nitrocellulose membranes.
All blots were first probed using a polyclonal antibody
anti-phospho-STAT-1 (Tyr701) (Cell Signaling, Boston,
MA) (1 : 100, overnight) and a polyclonal antibody anti-
STAT-1 (1 : 100; 1 hr) (Cell Signaling Technology Inc).
Revelation was performed with an enhanced chemolumi-
nescent system (GE Healthcare, Chalfont St Giles, UK)
followed by autoradiography. b-actin (Sigma) was used as
housekeeping protein to normalize differences in protein
loading. Data underwent densitometric analysis and were
expressed as densitometric arbitrary units by normaliza-
tion with the density of the band obtained for b-actin.
STAT-1 activation was assessed by calculating ratio of
pSTAT-1/STAT-1 expression.
Chromatin immunoprecipitation analysis
Chromatin immunoprecipitation (ChIP) analysis was
performed using the EZ-ChIP kit (Upstate-Millipore
Corporate, Billerica, MA) following the manufacturer’s
directions. The 16HBE cells stimulated with CSE 10%
were treated with formaldehyde and the cross-linked
chromatin was sonicated to lengths spanning 200–
1000 bp. The samples were pre-cleared with 60 ll Pro-
tein A–Agarose and then incubated with a polyclonal
antibody anti-human STAT-1. Immunocomplexes were
precipitated using Protein A–Agarose. After washing,
DNA fragments were isolated and purified with col-
umns. The PCR was performed using primers spanning
the promoter region 3537 of ICAM-1 gene using the
primers: 5′-CAC AGA GTG AGA CTC CAT C-3′ (the
forward) and 5′-TGT TGT CCA GGC TGG AGT A-3′
(the reverse).
Statistics
Data are expressed as mean counts  standard deviation.
Comparison between different experimental conditions
was evaluated by paired t-test. P < 005 was accepted as
statistically significant.
Results
Mini-BAL from smokers increase BLT2 but decrease
PPAR-a expression in bronchial epithelial cells
Bronchial epithelial cells play a crucial role in the
inflammatory responses to external agents including cig-
arette smoke. The effects of mini-BAL supernatants from
smokers and non-smokers on the expression of pro-
(BLT2) and anti-inflammatory (PPAR-a) receptors for
LTB4 in bronchial epithelial cells were initially explored.
Mini-BALs from smokers and, at lower extent, mini-
BALs from non-smokers increased the expression of
BLT2 as both percentage of positive cells (133  3%
and 6  25% variation for smokers and non-
smokers, respectively) and GeoMean fluorescence inten-
sity (187  12% and 33  35% variation for smokers
and non-smokers, respectively) (Fig. 1a,b). Mini-BAL
from smokers, but not mini-BALs from non-smokers,
decreased PPAR-a expression as percentage of positive
cells (11  3% of variation) (Fig. 2a,b). The percentage
of positive cells indicates the number of positive cells.
The GeoMean gives a measure of the average content of
the antigen per cell. The findings that mini-BALs
reduced the percentage but not the GeoMean fluores-
cence intensity suggest that mini-BALs are able to
reduce the number of PPAR-a-positive cells without
modifying the PPAR-a content per cell.
In tissue samples, bronchial epithelial cells from smok-
ers showed an intense expression of BLT2 but a weak
PPAR-a expression. In contrast, bronchial epithelial cells
from non-smokers showed an intense expression of
PPAR-a but a weak BLT2 expression (Fig. 3a,b).
Mini-BALs from smokers increase neutrophil
adhesion and ICAM-1 expression in bronchial
epithelial cells
The increased expression of BLT2 may lead to increased
neutrophil adhesion and to increased ICAM-1 expres-
sion.7 Mini-BALs from smokers increased both neutrophil
adhesion to bronchial epithelial cells (Fig. 4) (43  19%
of variation) and ICAM-1 expression (71  31% of vari-
ation) in bronchial epithelial cells (Fig. 5). The effect on
ICAM-1 expression was related to BLT2/PPAR-a deregu-
lated expression, since BLT2 antagonist reduced while
PPAR-a antagonist further increased the ICAM-1 expres-
sion in bronchial epithelial cells stimulated with mini-
BALs from smokers (Fig. 5).
CSE increase BLT2 and neutrophil adhesion but
decrease PPAR-a expression in bronchial epithelial
cells
To assess whether the exposure to cigarette smoke was
responsible for the effects induced by mini-BALs from
smokers, the direct effect of CSE was tested. The effects
of two different CSE concentrations (10 or 20%) on cell
necrosis/apoptosis were initially assessed. Since CSE 20%
increased cell apoptosis more than CSE 10% (Fig. 6), this
latter concentration was used for assessing BLT2 or
PPAR-a expression. The CSE increased BLT2 (29  13%
of variation) (Fig. 7) but decreased PPAR-a (13  8% of
variation) expression (Fig. 8) in bronchial epithelial cells.
Moreover, when bronchial epithelial cells were stimulated
with CSE, an increased neutrophil adhesion occurred
(29  19% of variation) (Fig. 9).
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Figure 2. Mini-bronchoalveolar lavages (mini-BALs) from smokers decrease peroxisome proliferator-activated receptor-a (PPAR-a) expression in
bronchial epithelial cells. Bronchial epithelial cells (16HBE) were cultured with/without mini-BALs from smokers (n = 5) and from non-smokers
(n = 3) for 18 hr and were used for assessing PPAR-a expression by flow cytometry (see Materials and methods for details). (a) Representative
histogram plots. 1 = negative control; 2 = baseline expression of PPAR-a; 3 = a mini-BAL from smoker. (b) The results are expressed as percent-
age of positive cells and as GeoMean fluorescence intensity  SD.Two replicates were performed from each mini-BAL sample. *P < 005
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Figure 1. Mini-bronchoalveolar lavages (mini-BALs) from smokers increase BLT2 expression in bronchial epithelial cells. Bronchial epithelial cells
(16HBE) were cultured with or without mini-BALs from smokers (n = 5) and from non-smokers (n = 3) for 18 hr and were used to assess
BLT2 expression by flow cytometry (see Materials and methods for details). (a) Representative examples of flow cytometric analysis. 1 = negative
control; 2 = BLT2 baseline expression; 3 = BLT2 expression after a mini-BAL from smoker exposure. (b) The results are expressed as percentage
of positive cells and as GeoMean fluorescence intensity  SD. Two replicates were performed from each mini-BAL sample.*P < 005
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CSE increase ICAM-1, STAT-1 activation and the
binding of STAT-1 to ICAM-1 promoter in bronchial
epithelial cells
Exposure to CSE increased ICAM-1 expression
(35  12% of variation) in bronchial epithelial cells and
this phenomenon was reduced by a BLT2 antagonist
(20  7% of variation) which was further increased by a
PPAR-a antagonist (22  2% of variation) (Fig. 10).
Silencing experiments for BLT2 and for PPAR-a con-
firmed the results obtained with BLT2 or PPAR antago-
nists. Moreover, the mechanisms promoting the increased
ICAM-1 expression in CSE-treated cells were explored by
assessing the activation of STAT-1 and by assessing the
binding of STAT-1 to ICAM-1 promoter. When bronchial
epithelial cells were exposed to CSE, an increased expres-
sion of phosphorylated STAT-1 occurred (Fig. 11a) and
an increased pSTAT-1/STAT-1 ratio was observed
(Fig. 11b). ChIP assays with anti-STAT-1-specific anti-
bodies showed that STAT-1 was detected on the pro-
moter region of ICAM-1 in bronchial epithelial cells to a
greater extent after CSE exposure (Fig. 11c). These data
provide further evidence that ICAM-1 expression is regu-
lated by STAT-1 activation.
Discussion
Long-term cigarette smoking is the major aetiological
factor for the development of COPD. Airway inflammation
and oxidative stress are implicated in the pathogenesis of
COPD. Leukotriene B4, a potent lipid mediator of
inflammation generated from arachidonic acid via the
5-lipoxygenase pathway, actively contributes to the inflam-
matory processes in smokers and in COPD patients.17
The present study demonstrates for the first time that
the response of the bronchial epithelium to LTB4 is the
result of a balance between the activation of receptors for
LTB4 with a pro-inflammatory outcome (BLT2) and with
an anti-inflammatory outcome (PPAR-a). Cigarette
Smoker Smoker
Non-smoker Non-smoker
(a) (b)
Figure 3. Expression of BLT2 and peroxisome proliferator-activated
receptor-a (PPAR-a) molecules in bronchial epithelial cells from sur-
gical samples of smokers. Immunohistochemistry for BLT2 (a) and
PPAR-a (b) in central airways from surgical samples of smokers
(n = 5) and of non-smokers (n = 3) was performed. Representative
BLT2 and PPAR-a immunostaining at 400 9 magnification was
shown.
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Figure 4. Mini-bronchoalveolar lavages (mini-BALs) from smokers
increase the adhesiveness between bronchial epithelial cells and neu-
trophils. Bronchial epithelial cells (16HBE) were cultured with/with-
out mini-BALs from smokers (n = 5) for 18 hr and were used for
assessing neutrophil adhesion to bronchial epithelial cells (see Mate-
rials and methods for details). Two replicates were performed from
each mini-BAL sample. The results are expressed as % of the fluores-
cence ratio of bound cells on total cells  SD. *P < 005
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Figure 5. Mini-bronchoalveolar lavages (mini-BALs) from smokers
increase intercellular adhesion molecule 1 (ICAM-1) expression in
bronchial epithelial cells. Bronchial epithelial cells (16HBE) were cul-
tured with/without mini-BALs from smokers (n = 5) and in the
presence of an inhibitor for BLT2 (LY255283; 1 hr pre-treatment) or
an inhibitor for peroxisome proliferator-activated receptor-a (PPAR-
a) (MK886; 1 hr pre-treatment) for 18 hr and were used for assess-
ing ICAM-1 expression by flow-cytometry (see Materials and meth-
ods for details). The results are expressed as GeoMean fluorescence
intensity  SD. Two replicates were performed from each mini-BAL
sample. *P < 005
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smoke generates an inflammatory milieu that promotes
the preferential activation of pro-inflammatory LTB4
receptors, activation of STAT-1, an up-regulation of
ICAM-1, and an increased adhesiveness between neu-
trophils and bronchial epithelial cells.
Neutrophils are a critical component of the host
defence against micro-organisms18; however, cessation of
neutrophil recruitment and clearance by apoptosis is
mandatory to restore homeostasis and limit host tissue
damage.19
Chronic neutrophilic inflammation is a frequent feature
in lung diseases including COPD; it mediates extensive
tissue damage and contributes to organ dysfunction.3
Leukotriene B4 induces neutrophil recruitment and acti-
vation in patients with COPD,17 it is higher in those with
COPD than in controls, it correlates with the number of
neutrophils20 and contributes to disease progression.21
100
10
0
101
10
1
102
10
2
103
10
3
104
10
4
Annexin V
PI
0·44%
1·94%1·31%
Baseline CSE 10% CSE 20%
100
10
0
101
10
1
102
10
2
103
10
3
104
10
4
Annexin V
PI
0·66%
3·1%1·51%
100
10
0
101
10
1
102
10
2
103
10
3
104
10
4
Annexin V
PI
0·57%
4·74%1·9%
Figure 6. Effect of cigarette smoke extract (CSE) in the apoptosis of bronchial epithelial cells. Bronchial epithelial cells (16HBE) were cultured in
the presence and in the absence of CSE (10%, 20%) and for 18 hr and then were used for assessing cell necrosis and cell apoptosis by annexin
V/propidium iodide (PI) method by flow cytometry (see Materials and methods for details). Representative dot plots showing the percentage of
annexin V, PI and annexin V/PI positive 16HBE at baseline and following the exposure of CSE (10%, 20%) are shown.
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Figure 7. Cigarette smoke extracts (CSE) increase BLT2 expression
in bronchial epithelial cells. Bronchial epithelial cells (16HBE) were
cultured in the presence and in the absence of CSE 10% for 18 hr
and were used for assessing BLT2 expression by flow cytometry (see
Materials and methods for details). (a) Representative histogram
plots. 1 = negative control; 2 = baseline expression of BLT2;
3 = CSE 10%. (b) The results are expressed as GeoMean fluores-
cence intensity  SD. *P < 005
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Figure 8. Cigarette smoke extracts (CSE) decrease peroxisome pro-
liferator-activated receptor-a (PPAR-a) expression in bronchial epi-
thelial cells. Bronchial epithelial cells (16HBE) were cultured in the
presence and in the absence of CSE 10% for 18 hr (n = 6) and were
used for assessing PPAR-a expression by flow cytometry (see Materi-
als and methods for details). (a) Representative histogram plots.
1 = negative control; 2 = baseline expression of PPAR-a; 3 = CSE
10%. (b) The results are expressed as GeoMean fluorescence inten-
sity  SD. *P < 005
ª 2013 Blackwell Publishing Ltd, Immunology, 139, 245–255 251
Role of cigarette smoke in LTB4 receptors
Leukotriene B4 uses a dual-receptor system because it
mediates its activity through the activation of pro-inflam-
matory transmembrane receptors (BLT1 and BLT2) and
of an anti-inflammatory nuclear receptor (PPAR-a). Our
group has previously demonstrated that pleural mesothe-
lial cells, expressing both pro-inflammatory transmem-
brane BLT2 receptor and anti-inflammatory nuclear
PPAR-a receptor, may provide an integrated response to
pleural LTB4 present in parapneumonic effusions.
7 The
transmembrane BLT2 receptor is expressed, other than by
leucocytes, by structural cells in a variety of body com-
partments and has a low binding affinity for LTB4.
7,22 A
previous study reports that BLT2 activation led to eleva-
tion of reactive oxygen species and subsequent activation
of nuclear factor-jB), so inducing the expression of vas-
cular cell adhesion molecule-1, which is known to be
involved in eosinophil infiltration into the airways.23 The
down-regulation of BLT2 with anti-sense BLT2 oligonu-
cleotides markedly attenuated airway inflammation and
airway hyper-responsiveness.23 The PPARs are transcrip-
tion factors that belong to the superfamily of nuclear
receptors. PPAR-a reduces pain and inflammation, inhib-
its the release of several pro-inflammatory and pro-angio-
genic enzymes24,25 and has also been reported to bind
and catabolise LTB4 and to limit inflammation. PPAR-a-
deficient mice exhibit a prolonged inflammatory response
when challenged with LTB4
26,27 and PPAR-a activation
inhibits nuclear factor-jB activation28 and down-regulates
chemoattractant production and neutrophil infiltration.29
In a rat model of CSE-induced emphysema, the treatment
with PPAR-a+c agonist for 4 weeks prevented the pro-
gression of emphysematous lung destruction.30
It has been previously demonstrated that BLT1 and
PPAR-a immunoreactivity is increased in the distal air-
ways of COPD patients compared with control subjects
but it does not significantly differ in smokers without
COPD.8 No information is available on BLT2 expression
and on the mechanisms promoted by the unbalanced
expression of BLT2 and PPAR-a on bronchial epithelial
cells.
Our results suggest that cigarette smoke and mini-BALs
from smokers, in vitro, in bronchial epithelial cells, shift
the emphasis of LTB4 towards a pro-inflammatory phe-
notype up-regulating BLT2 expression and down-regulat-
ing PPAR-a. In addition, bronchial epithelial cells from
smokers highly express BLT2 but not PPAR-a molecules.
These findings may be relevant to clarify some pathoge-
netic events leading to COPD because several studies pro-
vide evidence that the in vitro exposure to CSE
reproduces the in vivo changes observed within the air-
ways of smoking humans.31 Exposure to CSE up-regu-
lated the surface expression of ICAM-1 in human
umbilical vein endothelial cells32 and in bronchial epithe-
lial cells.33 Exposure of bronchial epithelial monolayers to
the combination of cigarette smoke followed by C5a
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Figure 9. Cigarette smoke extracts (CSE) increase neutrophil adhe-
sion to bronchial epithelial cells. Bronchial epithelial cells (16HBE)
were cultured in the presence and in the absence of CSE 10% for
18 hr (n = 6) and were used for assessing neutrophil adhesion to
bronchial epithelial cells. The results are expressed as % of the fluo-
rescence ratio of bound cells on total cells. *P < 005
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Figure 10. Cigarette smoke extracts (CSE) increase intercellular
adhesion molecule 1 (ICAM-1) expression in bronchial epithelial
cells. Bronchial epithelial cells (16HBE) were cultured in the presence
and in the absence of CSE 10%, of an inhibitor for BLT2
(LY255283; 1 hr pre-treatment) or of an inhibitor for peroxisome
proliferator-activated receptor-a (PPAR-a) (MK886; 1 hr pre-treat-
ment) (n = 6) and then were used for assessing ICAM-1 expression
by flow cytometry. In some experiments (n = 2), RNA interference
for BLT2 or PPAR-a was also performed. The results are expressed
as GeoMean fluorescence intensity  SD.*P < 005
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results in an additive response for ICAM-1 expression
and mononuclear cell adhesion compared with smoke or
C5a challenge alone.33
The contribution of LTB4 activity on ICAM-1 up-regu-
lation because of CSE is largely unexplored. Here, we
demonstrate that the treatment with CSE and mini-BALs
from smokers resulted in an up-regulated expression of
BLT2, which in turn increased ICAM-1 expression. Treat-
ment with a BLT2 antagonist reduced the generated
increased expression of ICAM-1. Moreover, CSE and
mini-BALs from smokers reduce the activation of PPAR-
a leading to increased ICAM-1 expression because the
presence of a PPAR-a antagonist increases the effects of
CSE and of mini-BALs from smokers in ICAM-1 expres-
sion. This finding is consistent with previous results
showing that mice lacking PPAR-a have increased expres-
sion of ICAM-1 in the lungs.34 The increased ICAM-1
expression, increasing the adhesiveness of bronchial
epithelial cells, may have several pathological conse-
quences in subjects who smoke. Cigarette smoke exposure
may play a critical role in rhinovirus-induced exacerba-
tions,35 compromising the innate responses against rhino-
virus infection36 and increasing the adhesion of viruses to
airway epithelial cells because ICAM-1 acts as cellular
receptor for the major group of rhinoviruses.37 In our
model, the increased ICAM-1 expression is associated
with increased neutrophil adhesion to bronchial epithelial
cells. This phenomenon may promote an increased accu-
mulation of neutrophils in the airways of smokers, so
contributing to airway neutrophilia, a common feature in
smokers and in patients with COPD. In this regard, it has
been previously demonstrated that epithelial ICAM-1 and
ICAM-2 regulate the passage of human T cells across the
bronchial epithelium.38
Finally, we investigated the molecular mechanisms lead-
ing to the increased ICAM-1 expression in CSE-stimu-
lated bronchial epithelial cells. The ICAM-1 is regulated
by tyrosine phosphorylation activity through STAT-1-
dependent signalling pathways.39 The effect of cigarette
smoke on STAT-1 activation is unclear and it is unknown
whether CSE per se interfere with STAT-1 activation in
bronchial epithelial cells. It has been demonstrated that
the pre-incubation with cigarette smoke reduces the inter-
feron-induced STAT-1 phosphorylation in bronchial epi-
thelial cells40 and that alveolar macrophages from
smokers have reduced STAT-1 phosphorylation,41 but
interferon-c synergistically enhances lipopolysaccharide
signalling in alveolar macrophages from patients with
COPD via STAT1 activation.42 Here, when bronchial epi-
thelial cells were exposed to CSE, an increased expression
of phosphorylated STAT-1 and an increased expression of
STAT-1 on the promoter region of ICAM-1 are detected.
Conclusions
Cigarette smoke and cigarette smoke-induced inflamma-
tion promote an imbalance between pro-inflammatory
and anti-inflammatory LTB4 receptors by up-regulating
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Figure 11. Cigarette smoke extracts (CSE) increase signal transducer and activator of transcription 1 (STAT-1) activation and its interaction with
the promoter of intercellular adhesion molecule 1 (ICAM-1) in bronchial epithelial cells. Bronchial epithelial cells (16HBE) were cultured in the
presence and in the absence of CSE 10% for 18 hr (n = 3) and were used for assessing STAT-1 or pSTAT-1 by Western blot analysis and for
chromatin immunoprecipitation assay (ChIP). (a) Representative Western blots of STAT-1, pSTAT-1 and b-actin expression. Lane 1 = baseline;
lane 2 = CSE 10%. (b) Signals corresponding to pSTAT-1 or to STAT-1 were semi-quantified by densitometric scanning, normalized for b-actin
and results were expressed as pSTAT-1/STAT-1 ratio.*P < 005. (c) ChIP assay using anti-STAT1 antibody and PCR using primers spanning the
promoter region 3537 of intercellular adhesion molecule 1 (ICAM-1) gene were performed (see Materials and methods for details) (n = 3). Lane
1 = DNA marker; lane 2 = negative control of PCR; lane 3 = baseline; lane 4 = CSE 10%.
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BLT2 and down-regulating PPAR-a in bronchial epithelial
cells. The prevalence of pro-inflammatory activities of
BLT2 upon cigarette smoke exposure in turn leads to
increased neutrophil adhesion, a mechanism contributing
to airway neutrophilia and to lung tissue damage. These
phenomena are frequently observed in smokers and in
patients with COPD.
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